option 2

Generic: levonorgestrel

Labeler: l. perrigo company
NDC Directory HUMAN OTC DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name option 2
Generic Name levonorgestrel
Labeler l. perrigo company
Dosage Form TABLET
Routes
ORAL
Active Ingredients

levonorgestrel 1.5 mg/1

Manufacturer
L. Perrigo Company

Identifiers & Regulatory

Product NDC 0113-2003
Product ID 0113-2003_81d8cf01-db5e-44c9-842b-eec3f3793ea1
Product Type HUMAN OTC DRUG
Marketing Category ANDA
Application Number ANDA202334
Listing Expiration 2026-12-31
Marketing Start 2016-01-29

Pharmacologic Class

Established (EPC)
progestin [epc] progestin-containing intrauterine system [epc]
Chemical Structure
progesterone congeners [cs]
Physiologic Effect
inhibit ovum fertilization [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01132003
Hyphenated Format 0113-2003

Supplemental Identifiers

RxCUI
483325 1736014
UNII
5W7SIA7YZW
NUI
N0000175830 M0447349 N0000175602 N0000175832

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name option 2 (source: ndc)
Generic Name levonorgestrel (source: ndc)
Application Number ANDA202334 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1.5 mg/1
source: ndc
Packaging
  • 1 BLISTER PACK in 1 CARTON (0113-2003-12) / 1 TABLET in 1 BLISTER PACK
source: ndc

Packages (1)

Ingredients (1)

levonorgestrel (1.5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "81d8cf01-db5e-44c9-842b-eec3f3793ea1", "openfda": {"nui": ["N0000175830", "M0447349", "N0000175602", "N0000175832"], "unii": ["5W7SIA7YZW"], "rxcui": ["483325", "1736014"], "spl_set_id": ["9b9e9352-3e4d-4ec3-96aa-8fd58d82fe96"], "pharm_class_cs": ["Progesterone Congeners [CS]"], "pharm_class_pe": ["Inhibit Ovum Fertilization [PE]"], "pharm_class_epc": ["Progestin [EPC]", "Progestin-containing Intrauterine System [EPC]"], "manufacturer_name": ["L. Perrigo Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 CARTON (0113-2003-12)  / 1 TABLET in 1 BLISTER PACK", "package_ndc": "0113-2003-12", "marketing_start_date": "20160129"}], "brand_name": "Option 2", "product_id": "0113-2003_81d8cf01-db5e-44c9-842b-eec3f3793ea1", "dosage_form": "TABLET", "pharm_class": ["Inhibit Ovum Fertilization [PE]", "Progesterone Congeners [CS]", "Progesterone Congeners [CS]", "Progestin [EPC]", "Progestin-containing Intrauterine Device [EPC]"], "product_ndc": "0113-2003", "generic_name": "levonorgestrel", "labeler_name": "L. Perrigo Company", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Option 2", "active_ingredients": [{"name": "LEVONORGESTREL", "strength": "1.5 mg/1"}], "application_number": "ANDA202334", "marketing_category": "ANDA", "marketing_start_date": "20160129", "listing_expiration_date": "20261231"}